CTLA4 and cancer: The impact of combination therapy with anti-PD-1 and anti-CTLA-4 in a clinical study of PWH on ART and cancer resulted in a modest increase in cell-associated unspliced HIV RNA, with no overall change in replication-competent HIV, although a decrease in inducible virus was observed in two participants using the quantitative viral outgrowth assay [97].